Radoss Labcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.27 Cr
as on 03-07-2024
- Revenue 91.52%
(FY 2023)
- Profit 220.06%
(FY 2023)
- Ebitda 36.58%
(FY 2023)
- Net Worth 100.92%
(FY 2023)
- Total Assets 35.05%
(FY 2023)
About Radoss Labcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.27 Cr.
Muneshbhai Dharajiya and Dalsukhbhai Aniyaliya serve as directors at the Company.
- CIN/LLPIN
U24299GJ2018PTC104683
- Company No.
104683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Radoss Labcare Private Limited offer?
Radoss Labcare Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Tables.
Who are the key members and board of directors at Radoss Labcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muneshbhai Dharajiya  | Director | 10-Oct-2018 | Current |
| Dalsukhbhai Aniyaliya | Director | 10-Oct-2018 | Current |
Financial Performance of Radoss Labcare.
Radoss Labcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.52% increase. The company also saw a substantial improvement in profitability, with a 220.06% increase in profit. The company's net worth Soared by an impressive increase of 100.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radoss Labcare?
In 2023, Radoss Labcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Radoss Cleanroom Equipments Private LimitedActive 2 years 10 monthsMuneshbhai Dharajiya and Dalsukhbhai Aniyaliya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 18 Oct 2023 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 11 Feb 2019 | ₹2.69 M | Open |
How Many Employees Work at Radoss Labcare?
Unlock and access historical data on people associated with Radoss Labcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radoss Labcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radoss Labcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
